2-acetamido-3-mercapto-L-propionamide,
N-Acetylcysteinamide,
N-Acetylcysteine amide,
N-Acetylcysteine amide,
38520-57-9,
(R)-2-acetamido-3-mercaptopropanamide,
NACA,
N-Acetyl-L-cysteinamide,
acetylcysteinamide,
N-Acetyl-L-cysteine amide,
UNII-4N69717RKW,
N-Acetylcysteinamide,
(2R)-2-acetamido-3-sulfanylpropanamide,
4N69717RKW,
AD4,
(R)- 2-(Acetylamino)-3-mercapto-Propanamide,
Acetylcysteine amide,
N-acetylcysteine amide;(R)-2-Acetamido-3-mercaptopropanamide,
Nac amide,
N-Acetyl cysteine amide,
N-Acetyl-cysteine-amide,
N-Acetylcysteine amide [WHO-DD],
N-Acetyl-cysteinamid,
Propanamide, 2-(acetylamino)-3-mercapto-, (2R)-,
Propanamide, 2-(acetylamino)-3-mercapto-, (R)-,
SCHEMBL377413,
DTXSID30436398,
UJCHIZDEQZMODR-BYPYZUCNSA-N,
15394-73-7,
KS-000001JN,
FCH907044,
MFCD01696115,
QC-247,
ZINC34380691,
AKOS006373417,
AK174779,
N-acetylcysteine amide, >=98% (HPLC),
AB0094969,
HY-110256,
(2R)-2-(Acetylamino)-3-mercaptopropanamide,
CS-0033121,
UNII-W8Y1TY74IN component UJCHIZDEQZMODR-BYPYZUCNSA-N,
glutathione,
AC-L-CYS-OH,
2-acetamido-3-mercapto-L-propionamide,
3-FLUOROBENZAMIDINE HYDROCHLORIDE,
CID10176265,
C487056,
10061-64-0,
GSH,